自免疫性疾病中的CAR-T细胞:在缓解的道路上
1Department of Internal Medicine 3 - Rheumatology and Immunology, FAU Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich Alexander Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Immunity
|November 16, 2024
概括
化学抗原受体 (CAR) T细胞疗法通过向B细胞显示出对自身免疫性疾病的前景. 专家们召开会议,讨论这项创新治疗的更广泛的临床应用的进展和战略.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
- 自免疫性疾病 自免疫性疾病
背景情况:
- 针对B细胞的仿制抗原受体 (CAR) T细胞正在成为自身抗体介导的自身免疫性疾病的可行治疗方法.
- 最近的进展突显了CAR T细胞治疗在各种自身免疫疾病中的治疗潜力.
研究的目的:
- 提出关于CAR T细胞治疗自身免疫性疾病的新数据.
- 讨论CAR T细胞疗法的有效临床转化策略.
- 总结第一个国际自身免疫CART创新者峰会的主要发现和发展.
主要方法:
- 国际专家峰会在德国格拉索召开 (2024年5月10日至12日).
- 讨论包括关于CAR T细胞治疗自身免疫力的研讨会和圆桌会议.
- 在峰会上介绍了最近的发现和关键发展的总结.
主要成果:
- 卡尔T细胞疗法在各种自身免疫性疾病中表现出潜力.
- 专家讨论的重点是优化临床翻译和应对关键挑战.
- 峰会促进了该领域的国际领导人之间的知识共享.
结论:
- 针对B细胞的CAR T细胞疗法是对自身免疫性疾病的一种有前途的方法.
- 进一步的研究和战略规划对于临床翻译至关重要.
- 国际合作是推动自身免疫CAR T细胞创新的关键.
相关概念视频
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
Autoimmune Disorders
390
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
390
Cell-mediated Immune Responses
67.2K
Overview
67.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480


![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)